Houda Hachad, PharmD

Interview

FDA Highlights Risks Associated With DPD Deficiency, Advises Testing Before Treatment

03/26/2025

This interview explores the US Food and Drug Administration’s (FDA) updated guidance on dihydropyrimidine dehydrogenase (DPD) deficiency and its implications for improving patient safety through pre-treatment DPYD testing before...

This interview explores the US...

03/26/2025

Journal of Clinical Pathways

Videos

Implementing PGx Testing in Oncology: Best Practices, Barriers, and Benefits

02/12/2025

Houda Hachad , PharmD;

Houda Hachad, PharmD, highlights best practices for implementing PGx testing in oncology and the barriers to its more widespread adoption.

Houda Hachad, PharmD, highlights...

02/12/2025

Journal of Clinical Pathways

Videos

Recommendations for Standardizing DPYD Pharmacogenomic Testing

01/31/2025

Houda Hachad , PharmD;

Houda Hachad, PharmD, breaks down the latest recommendations from the Association for Molecular Pathology for standardizing DPYD pharmacogenomic testing.

Houda Hachad, PharmD, breaks...

01/31/2025

Journal of Clinical Pathways